Astrana health, inc. announces share repurchase of 300,000 shares

Alhambra, calif. , jan. 21, 2025 /prnewswire/ -- astrana health, inc. ("astrana," and together with its subsidiaries and affiliated entities, the "company") (nasdaq: asth), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that on january 17, 2025, the company repurchased 300,000 shares of the company's common stock for the aggregate purchase price of $10.551 million, based on a purchase price per share of $35.17, which was the closing price per share on the nasdaq stock market on such date.
ASTH Ratings Summary
ASTH Quant Ranking